GNLX Competitors & Alternatives
Compare Genelux Corporation Common Stock with similar stocks in the same industry
Biotechnology
GNLX
Main Stock$2.98
Tradestie Score
59
Market Cap
$166.20M
Revenue Growth
-1.0%
Analyst Upside
+487.2%
Top Competitors
233 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
FBRX
Forte Biosciences, Inc. Common Stock
|
$76.61
|
$180.53M | - | 53 | Compare |
|
AVTX
Avalo Therapeutics, Inc. Common Stock
|
$18.05
|
$170.45M | - | 57 | Compare |
|
ACHV
Achieve Life Sciences, Inc.
|
$6.32
|
$158.43M | - | 48 | Compare |
|
NVCT
Nuvectis Pharma, Inc. Common Stock
|
$21.60
|
$154.27M | - | 61 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$11.81
|
$133.50M | - | 54 | Compare |
|
SRZN
Surrozen, Inc. Common
|
$21.78
|
$117.07M | - | 44 | Compare |
|
STTK
Shattuck Labs, Inc. Common Stock
|
$7.29
|
$114.01M | - | 50 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$27.27
|
$110.20M | - | 54 | Compare |
|
EUDA
EUDA Health Holdings Limited Ordinary Shares
|
$17.31
|
$73.94M | - | 53 | Compare |
|
RLMD
Relmada Therapeutics, Inc. Common Stock
|
$5.30
|
$71.69M | - | 49 | Compare |
More GNLX Analysis
Data updated: Aug 04, 2026 | Industry: Biotechnology (SIC 2834)
233 stocks in this industry